Dr. Mohammad Al-Katari

MBBS, MD, SB-MED, KSU-MED, SF-AH

Clinical

Clinical Fellow Physician in Hematology

Research Interests:

Clinical research in hematological malignancies particularly exploring genetic & molecular profiling in high risk patients with malignant hematological malignancies and its relation to treatment response to treatment, creating a tailored approach for various heterogeneous group of the patients with the same disease as that can have a tremendous effect in moving toward the right treatment without being exposed to unnecessary waist of money .

Brief Bio:

My name is Mohammad Sami Al-Katari, a clinical Fellow in Hematology at UHN - Princess Margaret Hospital since July 1st 2016, completed successfully 2 years Clinical Fellowship in Allogeneic Bone Marrow Transplant from July 2016 till June 2018 and I am currently doing another Clinical Fellowship in Leukemia / Lymphoma & Myeloma, which will be completed by end of June 2020. I obtained initially my Bachelor Degree in Medicine & Surgery (MBBS) from University of Aleppo "Accredited by FAIMER" in Syria in July 2003. After that, I was involved in the research for 2 years & then completed 4 years training in Internal Medicine where I've successfully obtained Saudi Board in Internal Medicine (SB-MED) in December 2010, King Saud University Fellowship in Internal Medicine in January 2011. Then, I completed successfully with the highest score Saudi Fellowship training Program in Adult Hematology& HSCT (SF-AH; 2 years program) in Feb 2014 with almost half of the training at Oncology Center & Bone Marrow Transplant Unit at King Faisal Specialist Hospital & Research Center. After that, I worked at King Saud University Medical City - King Khalid University Hospital (KSUMC-KKUH); (which is recognized by Accreditation Canada) in Riyadh, Saudi Arabia as an Internal Medicine & Adult Hematology Consultant (Staff Physician) until I joined my clinical Fellowship Program at PMH in July 2016 as mentioned above. I am very glad and excited joining the TRP as I do believe that it is the right program to enhance my skills as a clinician to translate our many theoretical research ideas into a real medical service or tool benefiting the patients in the field of malignant hematology.

Capstone Project:

Despite all the advancements, cancer can have devastating effects on different aspects of the patient's life. Regardless of increased survival rates, they may have poor quality-of-life due to various physical incapacities and mental health challenges due to their disease-related complications—existing data links patients’ health literacy on different aspects of their disease processes and better outcomes. Most recently, sudden implementation of virtual care during the current pandemic may have compromised the delivery or the effectiveness of patients' education. In response to these challenges, the Cancer Education Department at Princess Margaret Cancer Centre (PM) has launched a new educational digital tool through which clinicians can tailor and email the educational materials to cancer patients.

The study is proposed to elicit the patient educational preferences regarding current suboptimal use and delivery of educational materials to cancer patients. We aim to explore the barriers and gaps of underutilization of Digital Education Prescription (DEP) and ensure its suitability to the patients, caregivers, and clinicians to improve patients’ health literacy during the treatment journey.

Dr. Mohammad Al-Katari

MBBS, MD, SB-MED, KSU-MED, SF-AH

Clinical

Clinical Fellow Physician in Hematology

Research Interests:

Clinical research in hematological malignancies particularly exploring genetic & molecular profiling in high risk patients with malignant hematological malignancies and its relation to treatment response to treatment, creating a tailored approach for various heterogeneous group of the patients with the same disease as that can have a tremendous effect in moving toward the right treatment without being exposed to unnecessary waist of money .

Brief Bio:

My name is Mohammad Sami Al-Katari, a clinical Fellow in Hematology at UHN - Princess Margaret Hospital since July 1st 2016, completed successfully 2 years Clinical Fellowship in Allogeneic Bone Marrow Transplant from July 2016 till June 2018 and I am currently doing another Clinical Fellowship in Leukemia / Lymphoma & Myeloma, which will be completed by end of June 2020. I obtained initially my Bachelor Degree in Medicine & Surgery (MBBS) from University of Aleppo "Accredited by FAIMER" in Syria in July 2003. After that, I was involved in the research for 2 years & then completed 4 years training in Internal Medicine where I've successfully obtained Saudi Board in Internal Medicine (SB-MED) in December 2010, King Saud University Fellowship in Internal Medicine in January 2011. Then, I completed successfully with the highest score Saudi Fellowship training Program in Adult Hematology& HSCT (SF-AH; 2 years program) in Feb 2014 with almost half of the training at Oncology Center & Bone Marrow Transplant Unit at King Faisal Specialist Hospital & Research Center. After that, I worked at King Saud University Medical City - King Khalid University Hospital (KSUMC-KKUH); (which is recognized by Accreditation Canada) in Riyadh, Saudi Arabia as an Internal Medicine & Adult Hematology Consultant (Staff Physician) until I joined my clinical Fellowship Program at PMH in July 2016 as mentioned above. I am very glad and excited joining the TRP as I do believe that it is the right program to enhance my skills as a clinician to translate our many theoretical research ideas into a real medical service or tool benefiting the patients in the field of malignant hematology.

Capstone Project:

Despite all the advancements, cancer can have devastating effects on different aspects of the patient's life. Regardless of increased survival rates, they may have poor quality-of-life due to various physical incapacities and mental health challenges due to their disease-related complications—existing data links patients’ health literacy on different aspects of their disease processes and better outcomes. Most recently, sudden implementation of virtual care during the current pandemic may have compromised the delivery or the effectiveness of patients' education. In response to these challenges, the Cancer Education Department at Princess Margaret Cancer Centre (PM) has launched a new educational digital tool through which clinicians can tailor and email the educational materials to cancer patients.

The study is proposed to elicit the patient educational preferences regarding current suboptimal use and delivery of educational materials to cancer patients. We aim to explore the barriers and gaps of underutilization of Digital Education Prescription (DEP) and ensure its suitability to the patients, caregivers, and clinicians to improve patients’ health literacy during the treatment journey.